Abstract:Microneedles have garnered considerable attention over the years as a versatile pharmaceutical platform that could be leveraged to deliver drugs into and across the skin. In the current work, poly (N-isopropylacrylamide) (PNIPAm) is synthesized and characterized as a novel material for the development of a physiologically responsive microneedle-based drug delivery system. Typically, this polymer transitions reversibly between a swell state at lower temperatures and a more hydrophobic state at higher temperatures, enabling precise drug release. This study demonstrates that dissolving microneedles patches made from PNIPAm, incorporating BIS-PNIPAm, a crosslinked polymer variant, exhibit enhanced mechanical properties, evident from a smaller height reduction in microneedle (∼10%). Although microneedles using PNIPAm alone were achievable, it displayed poor mechanical strength, requiring the inclusion of additional polymeric excipients like PVA to enhance mechanical properties. In addition, the incorporation of a thermoresponsive polymer did not have a significant (p> 0.05) impact on the insertion properties of the needles as all formulations inserted to a similar depth of 500 μm into ex vivo skin. Furthering this, the needles were loaded with a model payload, 1,1'-dioctadecyl-3,3,3',3'-tetramethylindodicarbocyanine perchlorate (DID) and the deposition of the cargo was monitored via multiphoton microscopy that showed that a deposit is formed at a depth of ≈200 μm. Also, it was revealed that crosslinked-PNIPAm (Bis-PNIPAm) formulations exhibited notable skin accumulationof the dye only after 4 hours, independent of the excipient matrix used. This phenomenon was absent in non-crosslinked PNIPAm formulations, indicating a deposit formation in Bis-PNIPAm microneedle formulation. Collectively, this proof-of-concept study has advanced our understanding on the possibility to use PNIPAm for dissolving microneedle fabrication which could be harnessed for the deposition of nanoparticles into the dermis, for extended drug release within the skin.

Detachable Microneedles <i>via</i> Host-Guest Supramolecular Polymer Networks

PEGDA/PVP Microneedles with Tailorable Matrix Constitutions for Controllable Transdermal Drug Delivery

Two Photon Polymerization-Micromolding of Polyethylene Glycol-Gentamicin Sulfate Microneedles

Leveraging novel innovative thermoresponsive polymers in microneedles for targeted intradermal deposition

Polymeric Microneedles for Transdermal Protein Delivery

Hydrogel Microneedles with Programmed Mesophase Transitions for Controlled Drug Delivery

Polymer homologue-mediated formation of hydrogel microneedles for controllable transdermal drug delivery

Polymer Microneedles with Interconnected Porous Structures Via a Phase Inversion Route for Transdermal Medical Applications.

Fabrication of dissolving microneedles for transdermal delivery of protein and peptide drugs: polymer materials and solvent casting micromoulding method

Multilayered Pyramidal Dissolving Microneedle Patches with Flexible Pedestals for Improving Effective Drug Delivery

Extensible and swellable hydrogel-forming microneedles for deep point-of-care sampling and drug deployment

Transdermal Delivery of Therapeutics Through Dissolvable Gelatin/sucrose Films Coated on PEGDA Microneedle Arrays with Improved Skin Permeability

Microneedles Based on a Biodegradable Polymer—Hyaluronic Acid

Analyzing polymeric matrix for fabrication of a biodegradable microneedle array to enhance transdermal delivery

Recent advances in the design of polymeric microneedles for transdermal drug delivery and biosensing

Long-acting microneedles: a progress report of the state-of-the-art techniques

Improved Polyvinylpyrrolidone Microneedle Arrays With Non-Stoichiometric Cyclodextrin

Improved Polyvinylpyrrolidone Microneedle Arrays with Non-Stoichiometric Cyclodextrin.

Stimuli-responsive polymer microneedles: A rising transdermal drug delivery system and its applications in biomedical

Highly Porous Silk Fibroin Scaffold Packed in PEGDA/Sucrose Microneedles for Controllable Transdermal Drug Delivery

Biodegradable double-network GelMA-ACNM hydrogel microneedles for transdermal drug delivery